Research

Is It Time To Look At Healthcare Stocks?

For net-long healthcare investors, the last few years have been a particularly challenging time. Only a quarter of healthcare stocks have beaten the market over the last two years, the lowest percent of winners in at least two decades. Over the last few months, few investors have asked us about the healthcare sector.  We thought

Read More »

Level Set – Thoughts from Our Recent Travels

We have put forth the idea that the Fed will be more hawkish than what is in the price, as low unemployment and high CPI will prevent an incrementally dovish stance. Following a recent round of investor meetings, we do not think we have an out-of-consensus view – at least among equity investors. The potential

Read More »

Which Companies are Good and Bad at Buying Their Own Stock?

We believe that one of the most important roles of the senior management team of a company is to be good stewards of capital.  As such, we regularly analyze management decision making related to capital uses and the market’s reward or punishment for those actions. Today, we decided to evaluate the efficacy of corporate buybacks from two

Read More »

VIDEO – Artificial Intelligence: BID

Trivariate’s recent research on AI: Level Set – Changing Our Views: Three New Types of Stocks and Perverse Valuation? (Link) Growth: A.I. Risk Factor, Fed, And FAANGM (Link) Level Set – What “BID” AI Means For Valuation, And Taking Risk (Link)

Read More »

Level Set – What “BID” AI Means for Valuation, and Taking Risk

We continue to contemplate the possibility that all US equities might end up in one of three buckets based on the potential impact of AI – Beneficiaries, those that are Impregnable to AI, those that get Destroyed. We are using the acronym “BID” to reference these three buckets. Our suspicion is that companies that are

Read More »